制药研发生产率的分析 - - 需要一个新的视角
Alexander Schuhmacher1, Markus Hinder2, Alexander von Stegmann Und Stein3
1Technische Hochschule Ingolstadt, THI Business School, Esplanade 10, DE-85049 Ingolstadt, Germany; University of St. Gallen, Institute of Technology Management, Dufourstrasse 40a, CH-9000 St. Gallen, Switzerland.
Drug discovery today
|July 28, 2023
概括
制药研发生产率仍然是一个挑战. 20年来对16家公司的分析显示,支出增加,每种新药平均研发效率为61.6亿美元,往往需要并购.
科学领域:
- 制药行业 制药行业 制药行业
- 药物开发 药物开发
- 生物技术是生物技术.
背景情况:
- 研究和开发 (R&D) 的生产力是制药行业的一个持续挑战.
- 药物发现日益增加的成本和复杂性需要持续评估研发效率.
研究的目的:
- 分析20年期间 (2001-2020年) 领先的制药公司的研发投入,产出和成果.
- 评估研发效率并确定药物开发生产率的趋势.
主要方法:
- 分析研发支出,新药批准和企业战略 (包括合并和收购).
- 从2001年到2020年,对16家主要基于研究的制药公司进行了纵向研究.
主要成果:
- 制药公司每年增加了6%的研发支出,在2020年达到每家公司平均67亿美元.
- 这些公司推出了251种新药,占FDA药物评估和研究中心 (CDER) 批准的46%.
- 平均研发效率计算为每种新药的总研发支出为61.6亿美元.
结论:
- 许多领先的制药公司表现出负的研发生产率,往往需要并购来弥补赤字.
- 该研究强调了大量的研发投资,但每种新药的成本很高,这表明制药研发效率面临着持续的挑战.
相关概念视频
Analysis of Population Pharmacokinetic Data
297
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
297
Structure-Activity Relationships and Drug Design
770
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
770
Biopharmaceutics and Pharmacokinetics: Overview
2.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.1K
Drug Discovery: Overview
8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
184
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
184
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
95
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
95


